Catheter Segment Held Largest Share in US Pediatric Cardiology Market in 2023
According to our new research study on "US Pediatric Cardiology Market Forecast to 2031 – Country Analysis – by Product Type, Surgical Procedure, Disease Indication, and End User," the US pediatric cardiology market size is projected to reach US$ 3,599.40 million by 2031 from US$ 2,541.22 million in 2023. The market is expected to register a CAGR of 4.4% during 2023–2031. The US pediatric cardiology market report emphasizes trends prevalent in the market, along with drivers and deterrents affecting its growth. The surging incidences of congenital heart defects among pediatrics and a growing shift toward minimally invasive procedures are among the prominent factors fueling the US pediatric cardiology market growth. Apart from growth drivers, the report covers the US pediatric cardiology market trends and their foreseeable impact during the forecast period.
Growing Shift Toward Minimally Invasive Procedures Propel US Pediatric Cardiology Market Growth
Traditionally, open-heart surgery was the primary approach for addressing congenital heart defects and other cardiac conditions in children. However, the introduction of minimally invasive techniques has revolutionized treatment paradigms, offering several advantages, including less postoperative pain, reduced recovery times, and shorter hospital stays. The adoption of minimally invasive techniques remains essential in cardiac surgical procedures due to increased patient satisfaction, and it also provides a competitive edge to healthcare institutions in an ever-changing medical field. The ability to perform complex procedures through small incisions not only enhances recovery but also minimizes the risks associated with major surgeries, making these options particularly appealing for young patients. Minimally invasive procedures such as catheter-based interventions for atrial septal defects and patent ductus arteriosus closure have become increasingly common in pediatrics. Institutions such as Boston Children's Hospital and Texas Children's Hospital are leading the way in employing these techniques, utilizing advanced imaging technologies such as 3D echocardiography and fluoroscopy to guide precise interventions.
US Pediatric Cardiology Market
US Pediatric Cardiology Market Size and Forecast (2021 - 2031), Country Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Transcatheter Heart Valves, Occlusion Devices, Atherectomy Devices, Catheters, Stents, Introducer Sheaths and Others), Surgical Procedures (Interventional Procedures, Heart Rhythm Management Procedures and Others), End User (Hospitals, Specialty Clinics and Others), Disease Indication [Patient Foramen Ovale (PFO), Congenital Heart Disease, Acquired Heart Disease, Arrhythmias, Cardiomyopathies and Others], and Country
US Pediatric Cardiology Market Growth Report and Size by 2031
Download Free Sample
Advancements in robotic-assisted surgery are propelling the demand for minimally invasive procedures. Robotic systems allow for greater precision and control during procedures, facilitating operations such as valve repair and transcatheter aortic valve replacement in pediatric patients. Robotically assisted cardiac surgery is a feasible and safe approach for pediatric patients as they can easily perform surgeries that have small incisions. As training programs and clinical protocols for these techniques expand, more institutions are adopting minimally invasive approaches. Thus, the growing shift toward minimally invasive techniques, especially robotic systems for pediatric cardiology procedures, drives the US pediatric cardiology market.
The US pediatric cardiology market analysis has been carried out by considering the following segments: product type, application, and end user.
Based on product type, the US pediatric cardiology market is segmented into transcatheter heart valves, occlusion devices, atherectomy devices, catheters, stents, introducer sheaths, and others. The catheters segment held the largest US pediatric cardiology market share in 2023. Cardiac catheterization is one of the most widely performed cardiac procedures. Cardiac catheterization can help diagnose and treat different types of congenital and acquired heart conditions. Inoue Balloon Catheter, NC TREK NEO, and Z-Med Catheters are a few of the pediatric cardiac catheters that are used in the US. Hospitals launch various programs to provide technologically advanced catheterization services to treat heart diseases in pediatric patients. For instance, St. Louis Children's Hospital provides a pediatric cardiac catheterization program that includes expert care from doctors, the use of new technology for more accurate treatment and shorter recovery times, and a nationally accredited Catheterization Lab. Similarly, OHSU Doernbecher Children’s Hospital provides a heart catheterization program that helps diagnose and treat complex heart-related conditions without surgery. Thus, the growing number of programs by hospitals to monitor the heart health of children in the US and the increasing use of technologically advanced products for treatment in pediatrics is fueling the growth of the segment.
In terms of disease indication, the US pediatric cardiology market is segmented into patent foramen ovale, congenital heart disease, acquired heart disease, arrhythmias, cardiomyopathies, and others. The acquired heart disease segment held the largest share of the market in 2023. Numerous children are being diagnosed with conditions that are developed postnatally. These conditions include myocarditis, cardiomyopathy, and rheumatic heart disease, and their impact on child health is severe. Advancements in diagnostic tools such as echocardiography and cardiac MRI have significantly improved the capability to diagnose these early cases, along with proper intervention and management at the right time. Children's Hospital of Philadelphia and Texas Children's Hospital are developing protocols for the treatment of acquired heart disease as well as introducing specialization in the treatment of acquired heart diseases in children. With growing awareness about acquired heart diseases in children, the need for innovative treatments as well as inclusive long-term care strategies is increasing to achieve better outcomes for the affected children.
Based on surgical procedures, the US pediatric cardiology market is segmented into interventional procedures, heart rhythm management procedures, and others. The interventional procedures segment held the largest US pediatric cardiology market share in 2023. The interventional procedures segment is likely to grow strongly owing to the development of minimally invasive techniques and an increasing awareness of congenital heart defects in children. A catheter-based intervention for ASD, coarctation of the aorta, and pulmonary valve stenosis, among other conditions, is highly effective and does not require open-heart surgery. Shorter recovery times and less hospitalization are observed with the use of Amplatzer Septal Occluder and balloon dilation catheters. Pediatric cardiology teams are emphasizing training programs and collaborations from multidisciplinary teams to remain updated with the most recent techniques. Interventional procedures significantly improve the quality of care and long-term health outcomes of children suffering from cardiovascular conditions.
By end users, the US pediatric cardiology market is categorized into hospitals, specialty clinics, and others. The hospitals segment dominated the market in 2023. In the US pediatric cardiology market, the hospitals segment is significant in terms of delivering specialized care to children suffering from cardiovascular disorders. The increasing cases of congenital heart defects and other heart diseases have elevated pediatric cardiac centers with modern technologies and multidisciplinary teams for comprehensive treatment. Boston Children's Hospital, Texas Children’s Hospital, Seattle Children’s Hospital, and the Children's Hospital of Philadelphia are among the acknowledged leaders, boasting state-of-the-art facilities and innovative approaches to pediatric cardiology—including minimally invasive surgical techniques and interventional procedures. These hospitals emphasize collaborative care, where a cardiologist works with other surgeons, anesthesiologists, and nursing staff to ensure optimized treatment results. Seattle Children’s Hospital performed ~570 pediatric heart surgeries in 2023. Recent investments in telemedicine and remote monitoring technologies further enhance patient management, with constant care and follow-up, highly necessary for patients located in rural areas. Access to specialized care and treatment protocols enhanced in health systems ensures growth in the hospitals segment and advancements in pediatric cardiology, which will improve the quality of life for young patients suffering from cardiovascular problems.
Competitive Landscape
Abbott Laboratories, Medtronic Plc, Edwards Lifesciences Corp, Terumo Corp, W L Gore and Associates Inc, NuMED, Cordis Corp, Occlutech US LLC, Biotronik SE & Co KG, and RENATA MEDICAL are among the leading companies profiled in the US pediatric cardiology market report. The companies implement both organic (such as product launches, expansion, and product approvals) and inorganic (such as collaborations and partnerships) strategies to stay competitive in the market.
Contact Us
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com